Medpace Holdings (MEDP) Non-Current Deffered Revenue (2017 - 2018)
Medpace Holdings (MEDP) reported Non-Current Deffered Revenue of $4.0 million for Q3 2018, down 81.14% on a YoY basis from $21.0 million in Q3 2017, and down 64.26% quarter-over-quarter from $11.1 million in Q2 2018.
Medpace Holdings (MEDP) Non-Current Deffered Revenue (2017 - 2018) Analysis & Trends
Medpace Holdings has reported Non-Current Deffered Revenue for 2 years, with the latest figure at $4.0 million in Q3 2018.
- For the quarter ending Q3 2018, Non-Current Deffered Revenue fell 81.14% year-over-year to $4.0 million; the trailing twelve-month figure through Sep 2018 stood at $4.0 million (down 81.14% YoY), and the FY2017 full-year result was $11.5 million, changed N/A from the prior year.
- Non-Current Deffered Revenue for Q3 2018 stood at $4.0 million, down from $11.1 million in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $21.4 million in Q2 2017, with the low at $4.0 million in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | - |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 32.31 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | - |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | - |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 17.00 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | - |
| 10 | Medpace Holdings | 13.03 Bn | 12.38 Bn | 196.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 3.95 Mn |
| Jun 30, 2018 | 11.06 Mn |
| Mar 31, 2018 | 11.27 Mn |
| Dec 31, 2017 | 11.47 Mn |
| Sep 30, 2017 | 20.96 Mn |
| Jun 30, 2017 | 21.42 Mn |